China · Country watch
China-ROK FTA Advances, Skills Certification Crackdown
China finalizes trade talks with South Korea and proposes stricter rules to combat skills certification fraud, impacting trade and vocational sectors.
The picture Mixed How this is judged →
China's business environment shows mixed signals today. The China-ROK FTA advances bilateral trade, while new regulations target skills certification fraud. However, US concerns over China's biopharma sector highlight ongoing geopolitical tensions.
In this briefing China · vocational skills certification · Republic of Korea · Ministry of Commerce of the People's Republic of China · Brian Mast · United States Congress · biopharmaceutical sector
Regulation
China proposes tougher rules on skills certification fraud
China has proposed new regulations to curb fraud in vocational skills certifications, Sixth Tone reports. The draft regulation, the first of its kind, aims to prevent institutions from issuing certificates without proper assessments. This move is part of a broader effort to enhance the credibility and reliability of vocational training in China. The proposal highlights the government's focus on improving the quality of the workforce by ensuring that certifications accurately reflect skills and competencies.
Impact Vocational training providers in China face stricter compliance requirements, affecting certification processes.
Sources: Sixth Tone ↗
Trade
China-ROK FTA negotiations reach substantial conclusion
China and the Republic of Korea have substantially concluded the second phase of negotiations on the China-ROK Free Trade Agreement, according to China's Ministry of Commerce. This development marks a significant step forward in enhancing bilateral trade relations. The agreement aims to reduce tariffs and expand market access between the two countries, fostering increased economic cooperation. The completion of this negotiation phase is expected to boost trade volumes and strengthen economic ties in the region.
Impact Exporters and importers in China and South Korea gain from reduced tariffs and expanded market access.
Sources: CGTN Business ↗
Politics
US panel warns of China's biopharma rise, urges curbs
A US congressional advisory body has warned about China's growing competitive advantage in the biopharmaceutical sector, according to the South China Morning Post. The report has fueled calls in Washington to curb cross-border ties in this industry. Despite these warnings, Chinese firms remain largely unfazed and continue to attract significant interest from Western companies, which are paying large upfront fees to license Chinese drugs. This development underscores the geopolitical tensions affecting the biopharmaceutical sector.
Impact Biopharmaceutical firms in China and the US face increased scrutiny and potential trade restrictions.
Sources: South China Morning Post Business ↗
Nothing significant reported today in Disruption · Internal tension · Safety & health · Companies · Markets.
Also today in the local press
- A股午评:三大指数收跌,超4500只个股飘绿 — ChinaNews.com
- ‘Hong Kong is back’ narrative built on more than hope and hype — ChinaMorningPost
- US crackdown on scam networks connected to Chinese-born tycoon Chen Zhi ramps up — ChinaMorningPost
- (深圳APEC)以船为喻,中国向亚太发出“同舟之约” — ChinaNews.com
- 今年前10个月上海市货物贸易进出口总值同比增长18.7% — ChinaNews.com
- New US chip restrictions could cool Southeast Asia’s booming M&A market, bankers warn — South China Morning Post Business
- US acts against Chinese telecoms firms hours after Trump-Xi meeting — ChinaMorningPost
- ‘Haven assets’: China’s battered consumer stocks back in demand amid AI slump — South China Morning Post Business
Sources in this briefing
Sources: each headline links to the original article on the publisher's site.